Clinical Trial Update: Dapagliflozin Effect on Glucose Variability in Patients Post Bariatric Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of dapagliflozin on glucose variability in patients after bariatric surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Dasman Diabetes Institute | Conditions: Bariatric Surgery Candidate, Type2 Diabetes | Phase 2 | Status: ENROLLING_BY_INVITATION